Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AngioDynamics Inc ANGO

Healthcare Medical Devices
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the... see more

Recent & Breaking News (NDAQ:ANGO)

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of AngioDynamics, Inc.

Business Wire July 18, 2017

ANGIODYNAMICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In AngioDynamics, Inc. To Contact The Firm

PR Newswire July 18, 2017

SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of AngioDynamics, Inc.

Business Wire July 18, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of FedEx Corporation (FDX)

PR Newswire July 18, 2017

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FedEx Corporation - FDX

PR Newswire July 18, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Rocket Fuel Inc. to Sizmek Inc. is Fair to Shareholders

Business Wire July 18, 2017

AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results

GlobeNewswire July 18, 2017

AngioDynamics to Report Fiscal 2017 Fourth Quarter and Full-Year Financial Results

GlobeNewswire July 7, 2017

AngioDynamics Announces FDA Clearance for The Solero Microwave Tissue Ablation System

GlobeNewswire June 7, 2017

AngioDynamics Lawsuit Alleges C.R. Bard is Violating Antitrust Laws, Harming Competition and Limiting Access

GlobeNewswire May 31, 2017

AngioDynamics to Present at the 2017 UBS Global Healthcare Conference

GlobeNewswire May 9, 2017

AngioDynamics to Present at the 41st Annual Deutsche Bank Health Care Conference

GlobeNewswire April 20, 2017

AngioDynamics Announces Pricing of Secondary Offering by Selling Stockholders

GlobeNewswire April 6, 2017

AngioDynamics Announces Secondary Offering of 2.35 Million Shares of Common Stock by Selling Stockholders

GlobeNewswire April 6, 2017

AngioDynamics Reports Fiscal 2017 Third Quarter Results

GlobeNewswire March 30, 2017

AngioDynamics To Host Investor Day on Thursday, April 6, 2017, in New York City

GlobeNewswire March 27, 2017

AngioDynamics to Report Fiscal 2017 Third Quarter Financial Results

GlobeNewswire March 20, 2017

AngioDynamics Receives CE Mark Certification for The Solero Microwave Tissue Ablation System

GlobeNewswire March 14, 2017

AngioDynamics to Present at the Barclays Global Healthcare Conference

GlobeNewswire March 8, 2017

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating AngioDynamics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

PR Newswire January 9, 2017